Mucin-1 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Mucin-1 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityMucin-1
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatcaprylic acid ammonium sulfate precipitate
Size0.1 mL
Concentration1.0 mg/ml
ApplicationsImmunohistochemistry (IHC)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThe antibody detects endogenous level of total Mucin-1 polyclonal antibody. The alpha subunit has cell adhesive properties.Can act both as an adhesion and an anti-adhesion protein.May provide a protective layer on epithelial cells against bacterial and enzyme attack. Ref.26 Ref.37 Ref.40 Ref.45 Ref.46 Ref.49 Ref.52 Ref.53 Ref.56. The beta subunit contains a C-terminal domain which is involved in cell signaling, through phosphorylations and protein-protein interactions. Modulates signaling in ERK, SRC and NF-kappa-B pathways. In activated T-cells, influences directly or indirectly the Ras/MAPK pathway.Promotes tumor progression. Regulates TP53-mediated transcription and determines cell fate in the genotoxic stress response.Binds, together wi
Immunogenn/a
Other Names[PUM; MUC1; Breast carcinoma-associated antigen DF3 Carcinoma-associated mucin; Episialin; H23AG; Krebs von den Lungen-6; KL-6; PEMT; Peanut-reactive urinary mucin; PUM; Polymorphic epithelial mucin; PEM; Tumor-associated epithelial membrane antigen; EMA; Tumor-associa]
Gene, Accession #Gene ID: 4582, NCBI: NP_001018016.1, UniProt: P15941
Catalog #MBS9415931
Price$320
Order / More InfoMucin-1 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.